Received May 18, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Z943X | — |
Hiberix liquid portion only administration (potential); Hiberix liquid portion only administration (potential); This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 6-month-old male patient who received Hib (Hiberix) (batch number Z943X, expiry date 08-DEC-2026) for prophylaxis. On 10-MAR-2026, the patient received Hiberix. On 10-MAR-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Hiberix liquid portion only administration (potential)) and inappropriate preparation of medication (Verbatim: Hiberix liquid portion only administration (potential)). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 27-APR-2026 This case is 1 of 7 cases reported by same reporter.; Sender's Comments: US-GSK-US2026057667:Same reporter/Different patient US-GSK-US2026057334:Same reporter/Different patient US-GSK-US2026057338:Same reporter/Different patient US-GSK-US2026057336:Same reporter/Different patient US-GSK-US2026057337:Same reporter/Different patient US-GSK-US2026057335:Same reporter/Different patient